WaldNJCuckleHBrockJH, et al.Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects. Lancet1977; 1: 1323–1332.
2.
WaldNJHackshawAKWaltersJ, et al.First and second trimester antenatal screening for Down’s syndrome: the results of the serum, urine and ultrasound screening study (SURUSS). J Med Screen2003; 10: 56–104.
3.
Hippisley-CoxJCouplandCBrindleP. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. Br Med J2017; 357: j2099.
4.
Garcia-ClosasMGunsoyNBChatterjeeN. Combined associations of genetic and environmental risk factors: implications for prevention of breast cancer. J Natl Cancer Inst2014; 106: dju305.
RouxACholertonRSicsicJ, et al.Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the “my personal breast screening” (MyPeBS) randomised clinical trial. BMC Cancer2022; 22: 507.
